Jacobs Levy Equity Management, Inc Eagle Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 121,559 shares of EGRX stock, worth $85,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121,559
Holding current value
$85,091
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.71 - $6.07 $450,983 - $737,863
121,559 New
121,559 $450,000
Q1 2024

May 15, 2024
SELL
$4.26 - $6.51 $22,803 - $34,848
-5,353 Reduced 34.38%
10,215 $53,000
Q4 2023

Feb 14, 2024
BUY
$4.63 - $15.21 $18,436 - $60,566
3,982 Added 34.37%
15,568 $81,000
Q3 2023

Nov 16, 2023
BUY
$15.21 - $22.88 $176,223 - $265,087
11,586 New
11,586 $182,000
Q4 2022

Feb 14, 2023
SELL
$24.98 - $39.77 $545,713 - $868,815
-21,846 Reduced 67.47%
10,531 $307,000
Q3 2022

Nov 15, 2022
BUY
$26.42 - $47.12 $121,109 - $215,998
4,584 Added 16.49%
32,377 $855,000
Q2 2022

Aug 15, 2022
SELL
$41.26 - $51.35 $2.85 Million - $3.55 Million
-69,097 Reduced 71.31%
27,793 $1.24 Million
Q1 2022

May 16, 2022
SELL
$44.58 - $52.6 $2.04 Million - $2.41 Million
-45,802 Reduced 32.1%
96,890 $4.8 Million
Q4 2021

Feb 14, 2022
SELL
$45.82 - $56.9 $935,048 - $1.16 Million
-20,407 Reduced 12.51%
142,692 $7.27 Million
Q3 2021

Nov 15, 2021
SELL
$43.79 - $55.78 $382,768 - $487,572
-8,741 Reduced 5.09%
163,099 $9.1 Million
Q2 2021

Aug 16, 2021
BUY
$36.86 - $44.5 $509,958 - $615,657
13,835 Added 8.76%
171,840 $7.36 Million
Q1 2021

May 17, 2021
BUY
$40.32 - $50.97 $118,339 - $149,596
2,935 Added 1.89%
158,005 $6.6 Million
Q4 2020

Feb 16, 2021
BUY
$41.72 - $51.34 $875,869 - $1.08 Million
20,994 Added 15.66%
155,070 $7.22 Million
Q3 2020

Nov 16, 2020
BUY
$37.02 - $51.28 $1.5 Million - $2.07 Million
40,446 Added 43.2%
134,076 $5.7 Million
Q2 2020

Aug 17, 2020
BUY
$43.24 - $55.02 $1.31 Million - $1.67 Million
30,389 Added 48.05%
93,630 $4.49 Million
Q1 2020

May 15, 2020
BUY
$34.37 - $60.07 $1.46 Million - $2.55 Million
42,381 Added 203.17%
63,241 $2.91 Million
Q4 2019

Feb 14, 2020
BUY
$54.32 - $64.31 $218,583 - $258,783
4,024 Added 23.9%
20,860 $1.25 Million
Q3 2019

Nov 14, 2019
BUY
$53.25 - $59.98 $31,417 - $35,388
590 Added 3.63%
16,836 $952,000
Q2 2019

Aug 13, 2019
BUY
$46.61 - $58.45 $757,226 - $949,578
16,246 New
16,246 $905,000

Others Institutions Holding EGRX

# of Institutions
68
Shares Held
8.56M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $9.11M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email